Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Conference Sponsor
1
2020 - 12 - 10
点击次数:
CrownBio is a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular, and metabolic disease research.Founded in 2006, CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today’s most advanced drug development challenges.Our portfolio translational platforms provide insight and understanding about a drug’s efficacy, pharmacological profile, and patient response profile. This reduce failure in the clinic and supports the selection of the right patients for the right therapy.CrownBio’s fast-paced R&D programs are yielding novel, yet well-validated models at the cutting-edge of disease research.In 2018, JSR Corporation acquired Crown Bioscience to be a strategic part of its global JSR Life Sciences division.
2
2020 - 11 - 20
点击次数:
Sichuan Kangcheng Biotechnology is a pre-clinical drug discovery contract research organization (CRO) located in the prosperous and time-honored city of Chengdu in Southwestern China. Founded and affiliated with Sichuan University West China Hospital, Kangcheng continues to develop innovative animal disease models ranging from rodents to non-human primates,including Cardiovascular diseases, CNS diseases, oncology, metabolic diseases, Ophthalmic diseases, Autoimmune diseases, Liver and Kidney diseases. We are particularly strong on minimally-invasive catheterization for cardio-cerebral vascular diseases, patient-derived xenograft models, molecular imaging, neurological studies augmented with automated behavioral assessment, dynamic CSF sampling from cisterna magna and gut microbiome studies. With a highly professional team, state-of-the-art equipment, and AAALAC-accredited animal facilities, we provide standard or customized preclinical screening or efficacy evaluation services to our domestic and international customers.  We have helped many clients win IND approval in both China and USA.
3
2020 - 11 - 12
点击次数:
施维雅是一家由非盈利性基金管理的国际制药公司,总部位于法国叙雷讷。施维雅在149个国家拥有强大的国际业务,在全球共有21,700名员工;2017年营业额为41.52亿欧元。作为一家完全独立的企业,集团将其25%的营业收入投入到药品研发工作中(不含仿制药),并将其所有利润用于企业发展。在心血管疾病、免疫炎症疾病、神经变性疾病、癌症和糖尿病等五个卓越领域持续不断的追求创新,是施维雅持续增长的动力。施维雅还提供药物开发以外的eHealth解决方案。关于施维雅中国1979年,施维雅成为首批进入中国的跨国企业之一。施维雅在中国注册有14种高品质创新药物;6大区域办公室是分设在北京、南京、上海、杭州、武汉和广州;拥有2070名员工,业务覆盖29个省市地区,施维雅中国已经成为集团最大的专业队伍;承诺关爱40年,施维雅中国已经在心血管、糖尿病等疾病领域,稳居行业领先地位;每天为300万中国患者提供治疗药物和方案。施维雅中国将不断加强在糖尿病、高血压、心衰等领域的产品组合,提供高质量创新产品和综合治疗方案;并将持续与行专业协会、学会合作,提升对慢病患者的诊疗水平。作为施维雅中国的一部分,施维雅(天津)制药有限公司于2000年在天津经济技术开发区注册成立,并投资建立现代化工厂,于2002年正式投产。目前,施维雅天津工厂正在进行全新制剂车间的扩建。施维雅中国研发中心成立于2001年。该研发中心负责在大中华地区开展地方性与国际性的临床研究。自2018年开始,施维雅致力于在中国寻找本土在研新药项目,审慎评估调研后的合适项目将引进总部持续开发合作。
6页次1/2首页Previous12Next尾页